TMO stock forecast
Our latest prediction for Thermo Fisher Scientific, Inc.'s stock price was made on the Feb. 3, 2020 when the stock price was at 318.34$.
In the short term (2weeks), TMO's stock price should underperform the market by -0.60%. During that period the price should oscillate between -5.17% and +3.48%.
In the medium term (3months), TMO's stock price should outperform the market by 0.92%. During that period the price should oscillate between -10.72% and +9.54%.Get email alerts
Create a solid portfolio with TMO
About Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment comprises of portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs, and vaccines as well as diagnosis of disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment gives diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment involves in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.
At the moment the company generates 25220M USD in revenues.
On its last earning announcement, the company reported a profit of 8.89$ per share.
The book value per share is 65.65$
Three months stock forecastFeb. 3, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|